Abstract:Meroapplanins A–E (1–5) with a 2,3,4,5-tetrahydropyridine fragment were isolated from the fruiting bodies of Ganoderma applanatum. Their structures were elucidated by comprehensive spectroscopic analyses. Their absolute configurations were established based on the X-ray diffraction, electronic circular dichroism (ECD), and calculated nuclear magnetic resonance (NMR) with DP4+ analysis. A plausible biosynthetic pathway for 1–5 was proposed. Furthermore, compounds 1–5, together with optically pure compounds 1a–4a and 1b–4b, were evaluated for their protective effects in PC12 cells damaged by H2O2. The results showed that 3b had protective activity with a cell viability of 82.58 ± 1.31%, compared with the model group (cell viability: 65.27 ± 1.48%).The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.joc.0c00842?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.joc.0c00842</a>.Crystallographic data (<a class="ext-link" href="/doi/suppl/10.1021/acs.joc.0c00842/suppl_file/jo0c00842_si_001.cif">CIF</a>)HPLC-MS, NMR, HRESIMS, ECD spectra, and calculated NMR data of compounds 1–5 (<a class="ext-link" href="/doi/suppl/10.1021/acs.joc.0c00842/suppl_file/jo0c00842_si_002.pdf">PDF</a>)This article has not yet been cited by other publications.

Meroterpenoids from the Fruiting Bodies of Ganoderma Ahmadii Steyaret and Their Protein Tyrosine Phosphatase 1B Inhibitory Activities

Meroterpenoids With Protein Tyrosine Phosphatase 1B Inhibitory Activities From the Fruiting Bodies of <i>Ganoderma ahmadii</i>

Anti-human immunodeficiency virus-1 protease activity of new lanostane-type triterpenoids from Ganoderma sinense.

Triterpenoids and meroterpenoids with α-glucosidase inhibitory activities from the fruiting bodies of Ganoderma australe

Isolation and Bioactivity Evaluation of Terpenoids from the Medicinal FungusGanoderma Sinense

Lanostane triterpenoids with anti-proliferative and PTP1B/α-glucosidase inhibitory activities from the fruiting bodies of Ganoderma calidophilum

Nor-triterpenoids from the fruiting bodies of Ganoderma lucidum and their inhibitory activity against FAAH

New Lanostane-Type Triterpenoids from the Fruiting Body of Ganoderma Hainanense

Meroterpenoids with a large conjugated system from Ganoderma lucidum and their inhibitory activities against renal fibrosis

Lanostane Triterpenes from the Tibetan Medicinal Mushroom Ganoderma leucocontextum and Their Inhibitory Effects on HMG-CoA Reductase and α-Glucosidase

Triterpenes and meroterpenes from Ganoderma lucidum with inhibitory activity against HMGs reductase, aldose reductase and α-glucosidase

Isolation and characterization of dihydropyran-ring containing meroterpenoids from Ganoderma lucidum and their inhibitory activity against renal fibrosis-related protein expression

Lanostane triterpenoids from the fruiting bodies of Ganoderma amboinense

Triterpenoids from the fruiting bodies of Ganoderma lucidum and their inhibitory activity against FAAH

Three New Lanostanoids From The Mushroom Ganoderma Tropicum

Ganospirones A-G, seven undescribed spiro-meroterpenoids from Ganoderma lucidum and their biological activities

Triterpenoids with neurotrophic activity from Ganoderma lucidum.

Meroapplanins A–E: Five Meroterpenoids with a 2,3,4,5-Tetrahydropyridine Motif from Ganoderma applanatum

Five Undescribed Meroterpenoids from Ganoderma Lucidum and Their Inhibitory Activities Against Renal Fibrosis

Ganoderterpene A, a New Triterpenoid from Ganoderma Lucidum, Attenuates LPS-Induced Inflammation and Apoptosis Via Suppressing MAPK and TLR-4/NF-κB Pathways in BV-2 Cells.

Terminal Cyclohexane-Type Meroterpenoids from the Fruiting Bodies of Ganoderma cochlear